Innovation Summit Keynote Speaker, Sean Harper: Yale is a Preeminent Lifescience Research Center

New Haven, CT –– The Office of Cooperative Research last month announced the selection of three prominent industry professionals as keynotes for the 2019 Yale Innovation Summit. Connecticut Venture Capitalist and Oak HC/FT Co-Founder & Managing Partner, Annie Lamont, Managing Partner of SV Health Partners,  Kate Bingham, and Managing Director of Westlake Village Biopartners Sean Harper who says Yale is a leader in lifescience research.

Get to know all of our keynotes.  Read our highlight of Annie Lamont and Kate Bingham

“I’m honored to have been asked to present a keynote address to the Yale Innovation Summit,” Harper offered. “Not only is Yale a preeminent lifescience research center but the Innovation Summit has become one of the key events in the life sciences community.”

“Yale has worked diligently to be a global leader in lifescience research for years,” said Jon Soderstrom, Managing Director of the Office of Cooperative Research. “Everything we do at OCR is to foster an innovation ecosystem that ensures that researchers have access to the resources they need to bring invaluable discoveries to the  market, with the ultimate goal of meeting previously unmet medical needs. Integral to that work is partnering with venture capitalists and biopharmaceutical entrepreneurs like Sean Harper. For all these reasons, we couldn’t be more pleased to have him join us as an Innovation Summit keynote speaker.”


Via his bio, Harper says his career has been driven by one central mission, which he gives as advice to entrepreneurs: “Focus on profound unmet medical needs, rather than market projections. Fill those needs and the rest will follow.”

During his decades-long career, Harper has helped bring dozens of novel therapies to patients in the areas of oncology, osteoporosis, cardiovascular disease, and migraine. Harper’s passion for science and medicine has reportedly benefited millions of patients worldwide. Named by Time as one of the 50 most influential people in healthcare in 2018, Harper’s perspective in both basic research and as a practicing physician make him an ideal addition to the slate of Innovation Summit Keynotes.

“I hope to be able to share some of my perspectives based on my role as head of R&D at a large biopharma company and my recent move into venture funding of startup biotechs,” Harper said.

Earlier in his time at Amgen, Harper held a number of key leadership positions, including establishing the translational medicine group focused on biomarker discovery, development and integration into early-stage clinical studies. He also held positions as head of Global Regulatory Affairs and Safety, and head of Global Development/Corporate Chief Medical Officer.

The Innovation Summit will take place at the Yale School of Management on May 8, 2019. Registration is open and free to the Yale community. Visit for more information.